In integrative psychiatry, TMS is one tool inside a larger plan rather than a stand-alone fix. The plan still rests on a careful diagnosis, medication decisions, psychotherapy, and attention to sleep, nutrition, physical health and stress. TMS fits into that picture as an evidence-based option for depression that has not responded to medication, while the other pieces address what TMS cannot.
This page explains how that combination works in practice, where the evidence is strong, where it runs out, and what a whole-person TMS plan could reasonably include. It describes an approach, not a guarantee, and every element should be tailored with your own psychiatrist.
What "integrative" means, and what it does not
Integrative psychiatry combines conventional psychiatric care, including diagnosis, medication and psychotherapy, with a closer look at the body and daily life: labs when indicated, nutrition, sleep, movement and stress. The site's overview of integrative versus traditional psychiatry explains the model, and the integrative psychiatry service page describes how the practice approaches it.
Integrative does not mean replacing evidence with preference. TMS is one of the best-studied brain stimulation treatments: European expert guidelines rate high-frequency TMS of the left prefrontal cortex for depression at Level A, their highest grade of evidence. Those same guidelines found that Level A or B evidence is not reached for any condition beyond a short list. An integrative plan keeps both facts in view.
Before TMS: looking for what else is going on
Depression that "won't respond" sometimes has company. Undertreated insomnia, alcohol use, thyroid problems, other medical conditions, medication interactions, or a diagnosis that needs revisiting can all make treatment look less effective than it is. New York Medicaid's TMS policy builds this in, requiring providers to "confirm the diagnosis and rule out other etiologies of depressive symptoms that can interfere with medication effectiveness."
In practice, an integrative evaluation before TMS may include:
- A full psychiatric history, including any periods of elevated mood that might suggest bipolar disorder
- A review of every medication and supplement, with doses and dates
- Questions about sleep, alcohol, cannabis and other substances
- Coordination with your primary care doctor and, when indicated, blood work
- A look at diet, activity and major life stressors
Which tests make sense depends on your history; there is no standard "TMS lab panel." The physician-level guide to ruling out medical causes before TMS goes into detail, and what is treatment-resistant depression? explains "pseudo-resistance," when treatment has not truly failed.
Some findings point away from TMS as the next step. Consensus guidance says people with psychotic symptoms or acute suicidal thoughts should be considered for other treatments with established efficacy, such as ECT. New York Medicaid likewise says TMS is not indicated for acute suicidality or psychotic depression.
If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.
TMS alongside medication
Many people continue their antidepressant during TMS. In the THREE-D trial, which compared two TMS protocols in 414 adults, participants stayed on stable antidepressant doses. The FDA clearances for adolescents describe TMS "as an adjunct," meaning alongside medication. Whether you continue, adjust or simplify medication is a decision for you and your prescriber, made before and during the course; can I keep taking my medications during TMS? covers the practical questions.
The combination may also matter after a course. In a 12-month randomized trial in China, relapse was lowest in people who received both monthly clustered TMS and an antidepressant (15.9%), compared with TMS alone (24.2%) or medication alone (44.4%). Those participants had recovered with medication rather than TMS, so the result does not translate directly, but it supports the idea that combined approaches deserve study. Thoughtful medication management is part of the integrative picture before, during and after TMS.
TMS alongside psychotherapy
Therapy and TMS do different jobs. TMS acts on brain circuits involved in mood; therapy builds skills, changes patterns of avoidance, and helps you use any lift in energy. Coverage rules reflect the value placed on therapy: New York Medicare requires a documented trial of evidence-based psychotherapy before covering TMS, and Cigna requires one in the current episode. Optum removed its psychotherapy requirement in 2023, so plans differ.
During a course, some people continue weekly therapy, and some start behavioral approaches that turn returning energy into action. The research on deliberately combining them is still limited; TMS and talk therapy together summarizes what is and is not known.
Sleep, alcohol and daily rhythm
Some lifestyle factors are relevant to TMS safety as well as mood. The 2021 international safety guidelines list sleep deprivation and increased alcohol use among factors that can lower seizure threshold, along with alcohol withdrawal. That is one reason TMS teams ask about sleep and drinking, and why steady sleep and moderation during a course are sensible.
Beyond safety, regular sleep, physical activity and social contact support mood generally. No published study reviewed for this guide shows that any of these habits makes TMS itself work better, and it would be misleading to promise that. Supporting a TMS course with sleep, movement and nutrition and caffeine, alcohol and sleep during TMS sort the evidence carefully.
Nutrition and supplements: keeping claims honest
Nutrition matters for overall health, and deficiencies can affect energy and mood. The practice's nutrition and supplement services and its piece on depression versus nutrient deficiency cover that ground. What the evidence does not show is that a supplement boosts TMS response. If you take supplements, list them at the TMS consultation like any medication so they can be reviewed for interactions and safety.
The same caution applies to combining TMS with other treatments in one package. Aetna classifies adjunctive ketamine given with TMS as experimental. The Clinical TMS Society has stated that a single-day protocol combining TMS with two off-label medications was not FDA-cleared and did not meet its threshold for recommendation. Esketamine (Spravato) is an FDA-approved option for treatment-resistant depression in its own right, with at least two hours of monitoring at each treatment session. Comparing these choices is covered in TMS vs ketamine therapy.
Measuring progress across the whole plan
When several things change at once, such as starting TMS, adjusting sleep and continuing therapy, it can be hard to tell what is helping. Regular rating scales give everyone the same yardstick. Insurers expect them too: New York Medicare requires validated scales such as the PHQ-9 to monitor response during a course. Tracking your progress during TMS explains the PHQ-9 and other measures.
Measurement also guards against expectations doing the talking. In sham-controlled TMS trials, people receiving sham treatment improve substantially on average, a pooled within-group effect of about 0.8 in one meta-analysis. That is not a reason for cynicism; hope and structure help people. It is a reason to track symptoms consistently and to change one major thing at a time where you can, so that decisions about medication or further TMS rest on clearer information.
Coordinating the care team
An integrative plan often involves several people: a psychiatrist overseeing TMS, a prescriber if that is someone else, a therapist, a primary care doctor, and sometimes a nutrition professional. The plan works best when they share information, with your consent, rather than each seeing a slice. Practical steps that help:
- Sign releases so the TMS psychiatrist, your prescriber and therapist can talk directly.
- Keep one up-to-date list of medications and supplements and bring it everywhere.
- Share your symptom scores with your therapist, so sessions can respond to what the numbers show.
- Agree on who you call first if mood drops or side effects appear.
The site's article on how psychiatrists coordinate care with therapists describes what that looks like day to day.
What an integrative TMS plan could include
| Phase | Possible elements | Evidence status |
|---|---|---|
| Before | Diagnostic review, medical contributors, medication and supplement review, sleep and substance screening | Standard good practice; required in part by some payers |
| During | TMS on an FDA-cleared device, regular symptom scales, continued or adjusted medication, therapy | TMS: strong for depression; combination specifics: still being studied |
| During | Regular sleep, limited alcohol, steady routine | Relevant to seizure-threshold safety; general mood support |
| After | Relapse-prevention plan, ongoing therapy and medication, monitoring, retreatment if needed | Durability data mixed; maintenance evidence limited |
| Throughout | Nutrition and movement suited to your health | Good for general health; not shown to boost TMS |
After a course, roughly half to about six in ten initial responders were still doing well at one year in studies, which is why an integrative plan continues past the last session. Life after TMS has a relapse-plan template.
When an integrative psychiatrist might say "not yet"
Taking the whole person seriously sometimes means delaying TMS. A psychiatrist may suggest first treating severe insomnia, addressing heavy drinking, finishing an adequate medication trial, or clarifying whether mood episodes suggest bipolar disorder. None of these is a refusal; each makes it more likely that TMS, if it comes next, is given a fair test. The physician-level article on TMS in an integrative, precision psychiatry practice discusses this in more depth.
The TMS guide covers each step of treatment, and the TMS therapy page explains how to ask about a consultation. For broader whole-person care, see functional psychiatry and metabolic psychiatry.
Sources
- Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clinical Neurophysiology, 2020. pubmed.ncbi.nlm.nih.gov
- New York State Medicaid Coverage of Therapeutic Transcranial Magnetic Stimulation (Medicaid Update, July 2025). New York State Department of Health, 2025. healthweb-back.health.ny.gov
- Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. Journal of Clinical Psychiatry, 2018. pmc.ncbi.nlm.nih.gov
- Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. The Lancet, 2018. pubmed.ncbi.nlm.nih.gov
- 510(k) Summary K231926: NeuroStar Advanced Therapy System. U.S. Food and Drug Administration, 2024. accessdata.fda.gov
- Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Translational Psychiatry, 2017. pubmed.ncbi.nlm.nih.gov
- LCD L33398 Transcranial Magnetic Stimulation (version 40). Wellpoint Federal via CMS Medicare Coverage Database, 2026. cms.gov
- Transcranial Magnetic Stimulation (Coverage Policy EN0383). Evernorth Health Services (Cigna), 2026. a.static.cigna.com
- Behavioral Clinical Policy: Transcranial Magnetic Stimulation (BH803TMS112025). Optum Behavioral Health Solutions, 2026. providerexpress.com
- Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clinical Neurophysiology, 2021. europepmc.org
- Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (Clinical Policy Bulletin 0469). Aetna, 2026. aetna.com
- Clinical TMS Society's Statement on Level of Evidence for Single-Day TMS combined with Medications. Clinical TMS Society, 2025. clinicaltmssociety.org
- SPRAVATO (esketamine) nasal spray, CIII - Prescribing Information. Janssen / DailyMed, 2026. dailymed.nlm.nih.gov
- Billing and Coding: Transcranial Magnetic Stimulation (A57528). Wellpoint Federal via CMS Medicare Coverage Database, 2026. cms.gov
- A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018. pubmed.ncbi.nlm.nih.gov
- Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis. Brain Stimulation, 2019. pubmed.ncbi.nlm.nih.gov
- A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. Journal of Clinical Psychiatry, 2014. pubmed.ncbi.nlm.nih.gov
FAQs
Does integrative psychiatry replace TMS or medication?
No. It combines conventional treatments such as medication, psychotherapy and, where appropriate, TMS with attention to physical health, sleep, nutrition and stress.
Will supplements make TMS work better?
There is no good evidence that they do. Bring a list of everything you take so it can be checked for interactions and safety.
Do I need blood tests before TMS?
There is no standard TMS lab panel. Your psychiatrist decides which tests make sense based on your history, often in coordination with your primary care doctor.
Can I keep seeing my therapist during TMS?
Yes, and many people do. Therapy can help you use the energy and motivation that may return as mood improves.
Is lifestyle change enough instead of TMS?
For some people with milder symptoms, sleep, activity and therapy changes are a reasonable first step. For depression that has not responded to medication, they are usually a complement rather than a replacement. Am I a candidate for TMS? can help you think it through.
